Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 40 to 85

Using Transcranial Magnetic Stimulation and Language Therapy to Improve Mild Aphasia

Official title: Personalized Transcranial Magnetic Stimulation and Constraint Induced Language Therapy to Treat Mild Post-Stroke Aphasia

Run by University of Pennsylvania · NCT06842745 · Data updated 2026-11-12

This study is testing whether combining brain stimulation with speech therapy can help people with mild aphasia after a stroke improve their speaking and understanding skills.

Quick facts

PhasePhase 2
Study typeInterventional
Ages40 Years to 85 Years
SexAll
Enrollment24 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedFebruary 11, 2025
Main results expectedAugust 31, 2026
Study endsAugust 31, 2026
Registry record updatedMarch 5, 2026
Trial IDNCT06842745 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals who have had a left hemisphere stroke more than six months ago and exhibit mild aphasia.

Probably not a fit

Patients with ongoing substance abuse, other neurological disorders, or active psychiatric conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of combining Transcranial Magnetic Stimulation (TMS) with Speech-Language Therapy (SLT) to treat mild aphasia in individuals who have experienced a stroke. Participants will undergo a screening process, MRI, and then receive 10 consecutive sessions of TMS and SLT. The study aims to assess improvements in conversational speech and comprehension while also identifying specific characteristics that may predict treatment success. A comparison will be made between real TMS and sham TMS to evaluate the treatment's efficacy.

Why it matters

Potential benefit: If successful, this approach could significantly enhance communication abilities for patients with mild aphasia, improving their quality of life.

How similar studies have gone: Previous studies have shown that TMS can improve language performance in individuals with moderate to severe aphasia, but this approach for mild aphasia is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Left Hemisphere stroke
* Stroke occurred more than 6 months ago
* Mild Aphasia (WAB AQ score \> 85)
* Proficient in English

Exclusion Criteria:

* Ongoing substance or alcohol abuse
* Other neurological disorders, beside stroke (i.e. dementia, traumatic brain injury, multiple sclerosis)
* Active psychiatric disorders (i.e. bipolar disorder, schizophrenia)
* Pacemaker or cardiac defibrillator
* Diagnosis of tinnitus
* Epilepsy, or seizure in the past 6 months

Where it's running

  • University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.